Antiviral antibiotics: inhibition of focus-formation in human or mouse cell cultures by sarcoma-inducing oncornaviruses with rifamycins.
D000818:Animals; D000998:Antiviral Agents; D002460:Cell Line; D002471:Cell Transformation, Neoplastic / Q000187:drug effects*; D002478:Cells, Cultured; D002848:Chromatography, DEAE-Cellulose; D004254:DNA Nucleotidyltransferases / Q000378:metabolism; D012321:DNA-Directed RNA Polymerases / Q000378:metabolism; D017988:Gammaretrovirus / Q000187:drug effects / Q000201:enzymology; D006801:Humans; D051379:Mice; D009858:Oncogenic Viruses / Q000187:drug effects / Q000201:enzymology*; D012328:RNA Viruses / Q000187:drug effects / Q000201:enzymology*; D012293:Rifampin / Q000494:pharmacology; D012294:Rifamycins / Q000494:pharmacology*; D012513:Sarcoma, Experimental; D013154:Spleen; D013329:Structure-Activity Relationship; D014316:Tritium
D000998:Antiviral Agents; D012294:Rifamycins; D014316:Tritium; D004254:DNA Nucleotidyltransferases; D012321:DNA-Directed RNA Polymerases; D012293:Rifampin